Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
The Director, US Marketing Operations is responsible for establishing and leading the tactical execution of marketing operations, with a focus on launch readiness for Dyne's lead assets in Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1).
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
Dyne Therapeutics